97 related articles for article (PubMed ID: 20690207)
21. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
[TBL] [Abstract][Full Text] [Related]
22. [Inherited breast and ovarian cancers].
Gerdes AM; Ejlertsen B
Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
[TBL] [Abstract][Full Text] [Related]
23. Disease family history and modification of breast cancer risk in common BRCA2 variants.
Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
[TBL] [Abstract][Full Text] [Related]
24. [Recommendations for the management of women with an increased genetic risk of gynaecological cancer].
Verheijen RH; Boonstra H; Menko FH; de Graaff J; Vasen HF; Kenter GG
Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2414-8. PubMed ID: 12518519
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis of the ATR gene in breast and ovarian cancer families.
Heikkinen K; Mansikka V; Karppinen SM; Rapakko K; Winqvist R
Breast Cancer Res; 2005; 7(4):R495-501. PubMed ID: 15987455
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
27. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
28. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
29. Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer.
Aloraifi F; Boland MR; Green AJ; Geraghty JG
Surg Oncol; 2015 Jun; 24(2):100-9. PubMed ID: 25936246
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer susceptibility: current knowledge and implications for genetic counselling.
Ripperger T; Gadzicki D; Meindl A; Schlegelberger B
Eur J Hum Genet; 2009 Jun; 17(6):722-31. PubMed ID: 19092773
[TBL] [Abstract][Full Text] [Related]
32. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
Kleibl Z; Kristensen VN
Breast; 2016 Aug; 28():136-44. PubMed ID: 27318168
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer genome-wide association studies: there is strength in numbers.
Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
[TBL] [Abstract][Full Text] [Related]
34. Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
Angeli D; Salvi S; Tedaldi G
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046255
[TBL] [Abstract][Full Text] [Related]
35. The continuing search for predisposing colorectal cancer variants.
Picelli S; Von Holst S; Wessendorf P
Cancer Genomics Proteomics; 2009; 6(6):305-16. PubMed ID: 20065317
[TBL] [Abstract][Full Text] [Related]
36. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
Wendt C; Margolin S
Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
[TBL] [Abstract][Full Text] [Related]
37. Genetics and the management of women at high risk for breast cancer.
Mincey BA
Oncologist; 2003; 8(5):466-73. PubMed ID: 14530500
[TBL] [Abstract][Full Text] [Related]
38. Hereditary genes and SNPs associated with breast cancer.
Mahdi KM; Nassiri MR; Nasiri K
Asian Pac J Cancer Prev; 2013; 14(6):3403-9. PubMed ID: 23886119
[TBL] [Abstract][Full Text] [Related]
39. Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population.
Boujemaa M; Mighri N; Chouchane L; Boubaker MS; Abdelhak S; Boussen H; Hamdi Y
PLoS One; 2022; 17(3):e0265638. PubMed ID: 35333900
[TBL] [Abstract][Full Text] [Related]
40. Genetics of breast cancer: a topic in evolution.
Shiovitz S; Korde LA
Ann Oncol; 2015 Jul; 26(7):1291-9. PubMed ID: 25605744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]